Arialys Therapeutics
Arialys Therapeutics is a startup headquartered in La Jolla, United States, founded in 2021. It has raised at least $14.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Arialys Therapeutics has raised at least $14.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Arialys Therapeutics sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in La Jolla
- A28 Therapeutics
- AeroRx Therapeutics
- DEPTH Health
- Enlaza Therapeutics
- Paulex Bio
- RightDevice
- Sylke
- Valora Therapeutics
Related
- Innovation profile of La Jolla
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Arialys Therapeutics do?
Arialys Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Arialys Therapeutics raised?
At least $14.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Arialys Therapeutics based?
Arialys Therapeutics is headquartered in La Jolla, United States.
When was Arialys Therapeutics founded?
Arialys Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.